Prior IA, Lewis PD, Mattos C (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res 72:2457–2467
CAS
Article
PubMed
PubMed Central
Google Scholar
Rauen KA, Schoyer L, McCormick F, Lin AE, Allanson JE, Stevenson DA, Gripp KW, Neri G, Carey JC, Legius E et al (2010) Proceedings from the 2009 genetic syndromes of the Ras/MAPK pathway: from bedside to bench and back. Am J Med Genet A 152A:4–24
Article
PubMed
Google Scholar
Bourne HR, Sanders DA, McCormick F (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348:125–132
CAS
Article
PubMed
Google Scholar
Bos JL, Rehmann H, Wittinghofer A (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell 129:865–877
CAS
Article
PubMed
Google Scholar
Cherfils J, Zeghouf M (2013) Regulation of small GTPases by GEFs, GAPs, and GDIs. Physiol Rev 93:269–309
CAS
Article
PubMed
Google Scholar
Stowe IB, Mercado EL, Stowe TR, Bell EL, Oses-Prieto JA, Hernandez H, Burlingame AL, McCormick F (2012) A shared molecular mechanism underlies the human rasopathies Legius syndrome and neurofibromatosis-1. Genes Dev 26:1421–1426
CAS
Article
PubMed
PubMed Central
Google Scholar
Trahey M, McCormick F (1987) A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238:542–545
CAS
Article
PubMed
Google Scholar
Drosten M, Dhawahir A, Sum EY, Urosevic J, Lechuga CG, Esteban LM, Castellano E, Guerra C, Santos E, Barbacid M (2010) Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival. EMBO J 29:1091–1104
CAS
Article
PubMed
PubMed Central
Google Scholar
Blasco RB, Francoz S, Santamaria D, Canamero M, Dubus P, Charron J, Baccarini M, Barbacid M (2011) c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19:652–663
CAS
Article
PubMed
Google Scholar
Rojas AM, Fuentes G, Rausell A, Valencia A (2012) The Ras protein superfamily: evolutionary tree and role of conserved amino acids. J Cell Biol 196:189–201
CAS
Article
PubMed
PubMed Central
Google Scholar
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J (1994) Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527–532
CAS
Article
PubMed
Google Scholar
Castellano E, Sheridan C, Thin MZ, Nye E, Spencer-Dene B, Diefenbacher ME, Moore C, Kumar MS, Murillo MM, Gronroos E et al (2013) Requirement for interaction of PI3-kinase p110alpha with RAS in lung tumor maintenance. Cancer Cell 24:617–630
CAS
Article
PubMed
PubMed Central
Google Scholar
Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, Nicke B, Nye E, Stamp G, Alitalo K, Downward J (2007) Binding of Ras to phosphoinositide 3-kinase p110alpha is required for Ras-driven tumorigenesis in mice. Cell 129:957–968
CAS
Article
PubMed
Google Scholar
Murillo MM, Zelenay S, Nye E, Castellano E, Lassailly F, Stamp G, Downward J (2014) RAS interaction with PI3K p110alpha is required for tumor-induced angiogenesis. J Clin Invest 124:3601–3611
CAS
Article
PubMed
PubMed Central
Google Scholar
Shieh A, Ward AF, Donlan KL, Harding-Theobald ER, Xu J, Mullighan CG, Zhang C, Chen SC, Su X, Downing JR et al (2013) Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood 121(24):4884-4893. doi:10.1182/blood-2012-05-432252
Gentry LR, Martin TD, Reiner DJ, Der CJ (2014) Ral small GTPase signaling and oncogenesis: more than just 15 minutes of fame. Biochim Biophys Acta 1843:2976–2988
CAS
Article
PubMed
PubMed Central
Google Scholar
Stephen AG, Esposito D, Bagni RK, McCormick F (2014) Dragging ras back in the ring. Cancer Cell 25:272–281
CAS
Article
PubMed
Google Scholar
Cox AD, Fesik SW, Kimmelman AC, Luo J, Der CJ (2014) Drugging the undruggable RAS: mission possible? Nat Rev Drug Discov 13:828–851
CAS
Article
PubMed
PubMed Central
Google Scholar
McCormick F, Wittinghofer A (1996) Interactions between Ras proteins and their effectors. Curr Opin Biotechnol 7:449–456
CAS
Article
PubMed
Google Scholar
Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM (2013) K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503:548–551
CAS
Article
PubMed
PubMed Central
Google Scholar
Lim SM, Westover KD, Ficarro SB, Harrison RA, Choi HG, Pacold ME, Carrasco M, Hunter J, Kim ND, Xie T et al (2014) Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. Angew Chem Int Ed Engl 53:199–204
CAS
Article
PubMed
PubMed Central
Google Scholar
Marcus K, Mattos C (2015) Direct attack on RAS: intramolecular communication and mutation-specific effects. Clin Cancer Res 21:1810–1818
CAS
Article
PubMed
Google Scholar
Cox AD, Der CJ, Philips MR (2015) Targeting RAS membrane association: back to the future for anti-RAS drug discovery? Clin Cancer Res 21:1819–1827
CAS
Article
PubMed
Google Scholar
Zimmermann G, Papke B, Ismail S, Vartak N, Chandra A, Hoffmann M, Hahn SA, Triola G, Wittinghofer A, Bastiaens PI et al (2013) Small molecule inhibition of the KRAS-PDEdelta interaction impairs oncogenic KRAS signalling. Nature 497:638–642
CAS
Article
PubMed
Google Scholar
Yang MH, Laurent G, Bause AS, Spang R, German N, Haigis MC, Haigis KM (2013) HDAC6 and SIRT2 regulate the acetylation state and oncogenic activity of mutant K-RAS. Mol Cancer Res 11:1072–1077
CAS
Article
PubMed
PubMed Central
Google Scholar
Sasaki AT, Carracedo A, Locasale JW, Anastasiou D, Takeuchi K, Kahoud ER, Haviv S, Asara JM, Pandolfi PP, Cantley LC (2011) Ubiquitination of K-Ras enhances activation and facilitates binding to select downstream effectors. Sci Signal 4:ra13
Article
PubMed
PubMed Central
Google Scholar
Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, Miura J, Wiener HH, Wright L, Saba SG et al (2006) PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 21:481–493
CAS
Article
PubMed
Google Scholar
Plowman SJ, Ariotti N, Goodall A, Parton RG, Hancock JF (2008) Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Mol Cell Biol 28:4377–4385
CAS
Article
PubMed
PubMed Central
Google Scholar
Villalonga P, Lopez-Alcala C, Chiloeches A, Gil J, Marais R, Bachs O, Agell N (2002) Calmodulin prevents activation of Ras by PKC in 3T3 fibroblasts. J Biol Chem 277:37929–37935
CAS
Article
PubMed
Google Scholar
Wang MT, Holderfield M, Galeas J, Delrosario R, To MD, Balmain A, McCormick F (2015) KRas Promotes Tumorigenicity through Suppression of Non-canonical Wnt Signaling.Cell163(5):1237-1251. doi:10.1016/j.cell.2015.10.041